Senestech, Inc. (NASDAQ:SNES – Free Report) – Analysts at HC Wainwright issued their Q3 2025 EPS estimates for Senestech in a research note issued on Friday, August 8th. HC Wainwright analyst A. Dayal anticipates that the company will post earnings per share of ($0.35) for the quarter. HC Wainwright has a “Strong-Buy” rating on the stock. The consensus estimate for Senestech’s current full-year earnings is ($10.22) per share. HC Wainwright also issued estimates for Senestech’s Q4 2025 earnings at ($0.33) EPS and FY2029 earnings at $0.07 EPS.
Senestech (NASDAQ:SNES – Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported ($0.87) earnings per share (EPS) for the quarter. Senestech had a negative return on equity of 200.43% and a negative net margin of 289.01%. The business had revenue of $0.63 million during the quarter.
View Our Latest Stock Analysis on SNES
Senestech Stock Performance
Shares of NASDAQ SNES opened at $4.37 on Monday. The company has a quick ratio of 4.44, a current ratio of 5.83 and a debt-to-equity ratio of 0.07. The firm’s 50-day moving average price is $4.50 and its two-hundred day moving average price is $3.20. Senestech has a 52-week low of $1.30 and a 52-week high of $6.24. The stock has a market capitalization of $9.83 million, a P/E ratio of -0.80 and a beta of 0.20.
Institutional Investors Weigh In On Senestech
A hedge fund recently bought a new stake in Senestech stock. Geode Capital Management LLC purchased a new stake in shares of Senestech, Inc. (NASDAQ:SNES – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 11,647 shares of the company’s stock, valued at approximately $59,000. Geode Capital Management LLC owned about 0.52% of Senestech at the end of the most recent quarter. 5.19% of the stock is currently owned by institutional investors and hedge funds.
About Senestech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than Senestech
- Growth Stocks: What They Are, What They Are Not
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- Large Cap Stock Definition and How to Invest
- IPO Market Stays Hot With These 2 Debuting Stocks
- What is a SEC Filing?
- Taiwan Semiconductor Stock: Own It, Don’t Trade It
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.